Eurostars funding for therapeutic head and neck cancer vaccine project

We are extremely pleased to announce that 2A Pharma in collaboration with partners from The Danish Technological Institute and Danish biotech company DNA Sense have been granted EUR 653,000 Eurostars funding for 2AP07 , a project to develop a therapeutic head and neck cancer vaccine. Head and neck cancers represent the sixth most common cancer worldwide, resulting […]